| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 45,445,187 | 39,883,979 | 34,916,776 | | Cost of Revenue | 23,933,298 | 19,885,849 | 17,608,744 | | | Gross Profit | 21,511,889 | 19,998,131 | 17,308,032 | | | Operating Expenses | | Research Development | 4,151,678 | 3,277,523 | 2,589,779 | | Selling General and Administrative | 11,853,790 | 9,986,218 | 8,779,176 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 5,506,421 | 6,734,390 | 5,939,077 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (156,399) | 117,355 | 120,120 | | Earnings Before Interest And Taxes | 5,350,022 | 6,851,745 | 6,059,197 | | Interest Expense | 9,291 | 13,092 | 18,396 | | Income Before Tax | 5,340,732 | 6,838,653 | 6,040,801 | | Income Tax Expense | 1,784,747 | 2,351,896 | 2,085,157 | | Minority Interest | (124,442) | (140,602) | (130,914) | | | | Net Income From Continuing Ops | 3,431,543 | 4,346,155 | 3,824,730 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,431,543 | 4,346,155 | 3,824,730 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,431,543 | $4,346,155 | $3,824,730 |
|
0.22% Nasdaq 
Income Statement
